Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Sarcoma 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Rhabdomyosarcoma 2Prostatic Neoplasms 2Osteosarcoma 2Esophageal Neoplasms 2Craniopharyngioma 2Wilms Tumor 1Vascular Neoplasms 1Solitary Fibrous Tumors 1Solid Tumor 1Smooth Muscle Tumor 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Recurrent Head and Neck Carcinoma 1Oligodendroglioma 1Neurofibrosarcoma 1Neuroblastoma 1Nerve Sheath Neoplasms 1Neoplasms, Adipose Tissue 1Neoplasms 1Nasopharyngeal Carcinoma 1Myoepithelioma 1Mesothelioma, Malignant 1Meningioma 1Liposarcoma, Myxoid 1Liposarcoma 1Hodgkin Disease 1

Interventions

pazopanib 2Ifosfamide 2Doxorubicin 2selinexor 1Radiotherapy 1Radiation 1Proton Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytoma, Angiomatoid Fibrous × Proton Therapy × 90 days × Clear all
NCT06239272 2026-05-19

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
139 enrolled
Plasma cellSarcoma

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Glomus Tumor, Granuloma, Plasma Cell, Hemangiosarcoma, Liposarcoma, Myoepithelioma, Sarcoma, Osteosarcoma, Disorders of Sex Development, Granular Cell Tumor, Neoplasms, Adipose Tissue, Liposarcoma, Myxoid, Dermatofibrosarcoma, Sarcoma, Clear Cell, Smooth Muscle Tumor, Nerve Sheath Neoplasms, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Vascular Neoplasms, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡